Annual report
4021.TEDINET S100W4RP
Period2023-04-01 → 2024-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100TUZY. Amended by S100W5L5 (2025-06-25).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥226.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥228.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥209.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥206.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥48.2bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥52.3bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥51.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥55.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥43.9bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥40.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥51.8bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥56.6bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥38.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥41.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥33.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥30.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥38.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥41.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥323.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥298.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥279.7bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥265.5bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥249.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥92.6bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥77.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥230.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥221.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥208.0bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥200.6bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥185.5bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥22.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥29.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥22.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥30.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥33.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥39.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥18.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥22.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥25.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥25.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥272.82 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥291.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥231.73 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥210.09 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,641.05 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,557.12 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,454.01 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,384.13 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,264.23 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 70.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 17.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.5% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,137 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 2,965 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 2,737 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 2,688 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 2,640 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥181.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥183.2bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥170.0bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥162.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥160.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥40.9bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥41.8bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥45.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥46.4bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥46.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥39.3bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥37.5bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥44.9bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥47.2bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥34.6bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥36.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥34.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥30.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥29.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥257.6bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥241.8bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥231.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥225.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥213.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥80.5bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥67.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥177.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥174.7bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥168.4bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥165.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥155.4bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥14.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥21.7bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥248 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥256.49 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.21 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥212.52 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.76 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥164 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥164 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥122 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥104 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,277.1 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,245.72 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,188.84 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,152.93 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,068.43 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 19.7% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.6% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.1% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 138,800,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 141,300,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 143,000,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 145,000,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 146,000,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,011 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 1,959 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 1,929 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 1,924 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 1,890 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 122
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2023-04-01 → 2024-03-31 | ¥1.8bn |
| Otherother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥748m |
| Otherother segments | employees | at 2024-03-31 | 482 pure |
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥30.2bn |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥11.2bn |
| Otherother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥19.0bn |
| Otherother segments | segment assets | at 2024-03-31 | ¥21.1bn |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥572m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥468m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥471m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥115.8bn |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2024-03-31 | −¥27.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥88.7bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥30.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥4.9bn |
| Agrochemicalsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥6.8bn |
| Agrochemicalsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥3.3bn |
| Agrochemicalsreportable segment | employees | at 2024-03-31 | 710 pure |
| Agrochemicalsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥82.1bn |
| Agrochemicalsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥67.4bn |
| Agrochemicalsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥14.7bn |
| Agrochemicalsreportable segment | segment assets | at 2024-03-31 | ¥119.5bn |
| Agrochemicalsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥23.4bn |
| Chemicalsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥4.2bn |
| Chemicalsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| Chemicalsreportable segment | employees | at 2024-03-31 | 380 pure |
| Chemicalsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥35.6bn |
| Chemicalsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥23.5bn |
| Chemicalsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥12.1bn |
| Chemicalsreportable segment | segment assets | at 2024-03-31 | ¥33.2bn |
| Chemicalsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥48m |
| Medicinesreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥473m |
| Medicinesreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥367m |
| Medicinesreportable segment | employees | at 2024-03-31 | 105 pure |
| Medicinesreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥6.3bn |
| Medicinesreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥6.2bn |
| Medicinesreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥71m |
| Medicinesreportable segment | segment assets | at 2024-03-31 | ¥8.6bn |
| Medicinesreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.8bn |
| Performance Materialsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥9.4bn |
| Performance Materialsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥6.0bn |
| Performance Materialsreportable segment | employees | at 2024-03-31 | 888 pure |
| Performance Materialsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥84.6bn |
| Performance Materialsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥67.2bn |
| Performance Materialsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥17.4bn |
| Performance Materialsreportable segment | segment assets | at 2024-03-31 | ¥70.6bn |
| Performance Materialsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥22.5bn |
| Tradingreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥39m |
| Tradingreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥77m |
| Tradingreportable segment | employees | at 2024-03-31 | 203 pure |
| Tradingreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥103.8bn |
| Tradingreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥78.3bn |
| Tradingreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥25.5bn |
| Tradingreportable segment | segment assets | at 2024-03-31 | ¥40.0bn |
| Tradingreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥3.7bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥22.7bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥13.2bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥342.5bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥253.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥88.7bn |
| —segment total | segment assets | at 2024-03-31 | ¥293.0bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥53.1bn |
| Otherother segments | capex | 2022-04-01 → 2023-03-31 | ¥366m |
| Otherother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥442m |
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥26.4bn |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥12.1bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥14.3bn |
| Otherother segments | segment assets | at 2023-03-31 | ¥13.6bn |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥879m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥787m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥249m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥107.3bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2023-03-31 | −¥29.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥78.1bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥41.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥5.2bn |
| Agrochemicalsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥6.2bn |
| Agrochemicalsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2.7bn |
| Agrochemicalsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥81.6bn |
| Agrochemicalsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥70.3bn |
| Agrochemicalsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥11.3bn |
| Agrochemicalsreportable segment | segment assets | at 2023-03-31 | ¥104.0bn |
| Agrochemicalsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥23.1bn |
| Chemicalsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥3.7bn |
| Chemicalsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2.5bn |
| Chemicalsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥39.0bn |
| Chemicalsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥26.5bn |
| Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥12.5bn |
| Chemicalsreportable segment | segment assets | at 2023-03-31 | ¥34.2bn |
| Chemicalsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.4bn |
| Medicinesreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥449m |
| Medicinesreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥376m |
| Medicinesreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.7bn |
| Medicinesreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.7bn |
| Medicinesreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥11m |
| Medicinesreportable segment | segment assets | at 2023-03-31 | ¥7.7bn |
| Medicinesreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥3.0bn |
| Performance Materialsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8.7bn |
| Performance Materialsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥4.6bn |
| Performance Materialsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥82.6bn |
| Performance Materialsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥66.2bn |
| Performance Materialsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥16.4bn |
| Performance Materialsreportable segment | segment assets | at 2023-03-31 | ¥61.3bn |
| Performance Materialsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥25.4bn |
| Tradingreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥66m |
| Tradingreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥65m |
| Tradingreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥99.1bn |
| Tradingreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥75.5bn |
| Tradingreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥23.5bn |
| Tradingreportable segment | segment assets | at 2023-03-31 | ¥36.8bn |
| Tradingreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥3.7bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥19.5bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥10.6bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥335.4bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥257.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥78.1bn |
| —segment total | segment assets | at 2023-03-31 | ¥257.6bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥57.5bn |
| Agrochemicalsreportable segment | employees | at 2024-03-31 | 550 pure |
| Chemicalsreportable segment | employees | at 2024-03-31 | 380 pure |
| Medicinesreportable segment | employees | at 2024-03-31 | 105 pure |
| Performance Materialsreportable segment | employees | at 2024-03-31 | 607 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,860
| Item | Context | Value | Unit |
|---|---|---|---|
| Gross scope1 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior1YearDuration_ConsolidatedAccountingGroupMember | 230424 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior5YearDuration_ConsolidatedAccountingGroupMember | 128647 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior4YearDuration_ConsolidatedAccountingGroupMember | 116724 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior3YearDuration_ConsolidatedAccountingGroupMember | 116516 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior2YearDuration_ConsolidatedAccountingGroupMember | 124663 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior1YearDuration_ConsolidatedAccountingGroupMember | 115893 | |
| Gross scope1 and2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior5YearDuration_ConsolidatedAccountingGroupMember | 382432 | |
| Gross scope1 and2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior4YearDuration_ConsolidatedAccountingGroupMember | 345514 | |
| Gross scope1 and2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior3YearDuration_ConsolidatedAccountingGroupMember | 336759 | |
| Gross scope1 and2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior2YearDuration_ConsolidatedAccountingGroupMember | 363621 | |
| Gross scope1 and2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior1YearDuration_ConsolidatedAccountingGroupMember | 346316 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 71.0 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 70.0 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 144 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 160 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 66.0 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 70.0 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 64.9 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 70.0 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row5Member | 7.8 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row5Member | 7.0 | |
| Research and development expenses research and development activities | CurrentYearDuration | 17334000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00759-000ChemicalsReportableSegmentsMember | 256000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00759-000PerformanceMaterialsReportableSegmentsMember | 8172000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00759-000AgrochemicalsReportableSegmentsMember | 4306000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00759-000MedicinesReportableSegmentsMember | 440000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 23204000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00759-000PerformanceMaterialsReportableSegmentsMember | 9441000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 6831000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 138800000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 138800000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 138800000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 138800000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 68 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 48 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 267 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 610 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 22 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 10574 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 11589 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 639190 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 51818 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 123026 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 420577 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 91 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 152033 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 1386735 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |